BEGIN:VCALENDAR VERSION:2.0 PRODID:-//hacksw/handcal//NONSGML v1.0//EN BEGIN:VEVENT UID:ce6ca35bccd13434335fd3cf9e673a3b DTSTAMP:20260604T062636Z DTSTART:20241104T140000 DTEND:20241104T150000 SUMMARY:Assessing Programmatic Needs: Stakeholder Workshop Findings on Oral Cholera Vaccines Capsules (DuoChol) DESCRIPTION:Dear members,\nThe WHO, IVI and TechNet are pleased to invited you to a new webinar: 'Assessing Programmatic Needs: Stakeholder Workshop Findings on Oral Cholera Vaccines Capsules (DuoChol)'\nOral cholera vaccine capsules represent an innovation that could significantly enhance the efficiency of cholera vaccine delivery worldwide. To ensure this technology aligns with real-world needs, understanding country-specific demands and preferences is critical.\nJoin us for a webinar where we will share findings from consultations conducted with over 100 national stakeholders from Bangladesh, Tanzania, Kenya, Ethiopia, and Mozambique. We will explore key insights that emerged from these discussions.\nKey Highlights:\n- Identified barriers to cholera immunization\n- Desirable attributes of the innovation to address these barriers\n- Potential use cases for oral cholera vaccine capsules\n- Feasibility of introducing the capsule format\nAudience:\nThe primary audience for this webinar are regional and country colleagues, partners, and manufacturers actively engaged in cholera vaccination efforts.\n \nRegister here: https://tn21.org/duochol X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\n

Dear members,

The WHO, IVI and TechNet are pleased to invited you to a new webinar: 'Assessing Programmatic Needs: Stakeholder Workshop Findings on Oral Cholera Vaccines Capsules (DuoChol)'

Oral cholera vaccine capsules represent an innovation that could significantly enhance the efficiency of cholera vaccine delivery worldwide. To ensure this technology aligns with real-world needs, understanding country-specific demands and preferences is critical.

Join us for a webinar where we will share findings from consultations conducted with over 100 national stakeholders from Bangladesh, Tanzania, Kenya, Ethiopia, and Mozambique. We will explore key insights that emerged from these discussions.

Key Highlights:

- Identified barriers to cholera immunization

- Desirable attributes of the innovation to address these barriers

- Potential use cases for oral cholera vaccine capsules

- Feasibility of introducing the capsule format

Audience:

The primary audience for this webinar are regional and country colleagues, partners, and manufacturers actively engaged in cholera vaccination efforts.

\n\n\n LOCATION: END:VEVENT END:VCALENDAR